CClinicalTrials.gg
CompletedNCT02798094CAN-BIND-04Updated Aug 28, 2019

Stress Sensitivity and Reward Responsivity in Depression

An observational study in Depressed, sponsored by Dr. Kate Harkness. Completed at 1 site in Canada. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-28.

Sponsored by Dr. Kate Harkness · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
219
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this project is to learn more about the different ways in which people process information that is stressful and rewarding, and how abnormalities in these two processes are related to depression.

Read the detailed description

Participants will participate in two 3-hour sessions separated by a week at Providence Care, Mental Health Services, and a third, 1.5-hour session at the Queen's MRI Facility. At the first session participants will complete a packet of questionnaires about their mood and take part in an interview about their mood, medications, drug use, and any other symptoms, as well as an interview about their relationships with their parents and any experiences of abuse. At the second session participants will participate in a stress test, which involves giving a speech to a panel. The investigators will also collect saliva samples to look at stress hormones. Participants will also complete a task on the computer that involves looking at cartoon faces and making decisions about them. At the third session, the investigators take images of of participant's brain using a magnetic resonance scanner.

Participants are invited to participate in a 6-month follow-up for this study, which would involve the same procedure as outline above.

02

Conditions studied

  • Depressed

Browse trials for

03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 219 is above the median of 160 across 1,084 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

This is the only study on the registry with Dr. Kate Harkness as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Community sample

Eligibility criteria

For Depressed Participants:

Inclusion Criteria:

  • Outpatients aged 18-65
  • Currently suffering from unipolar depression
  • Fluency in English, sufficient to complete the interviews and self-report questionnaires

Exclusion Criteria:

  • Clinical diagnosis of bipolar disorder, psychotic disorders, current alcohol/substance dependence, or significant medical comorbidity
  • Treatment-resistant (defined as failing more than 3 trials of anti-depressant medication)
  • History of neurological insult (e.g., concussion), neurological disease, seizure disorder
  • Smokers
  • Pregnant women
  • Endocrine disorders
  • High suicidal risk, defined by clinician judgement

For Healthy Control Participants:

Inclusion Criteria:

  • Adults aged 18-65
  • No history of Axis I disorders according to DSM-IV-TR criteria, as determined by the SCID
  • No first-degree relatives diagnosed with bipolar disorder
  • Fluency in English, sufficient to complete the interviews and self-report questionnaires

Exclusion Criteria:

  • History of neurological insult (e.g., concussion), neurological disease, seizure disorder
  • Smokers
  • Pregnant women
  • Endocrine disorders
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
219 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Depressed Participants

    No intervention

  • Healthy Control Participants

    No intervention

06

What researchers measure

Primary outcomes

  1. Stress Sensitivity: Salivary Hormone and Stress Challenge Test (TSST)

    Participants are required to give a speech and an arithmetic test in front of a panel. Saliva samples are collected at 8 points throughout the test.

    Time frame: 2 hours after beginning of Time B Appointment

Secondary outcomes

  1. Mood and Anxiety Symptom Questionnaire (MASQ)

    Self-report scale of general distress (GD), anhedonic depression (AD), and anxious arousal (AA) symptoms

    Time frame: Administered at first baseline appointment and covers past 2 weeks

  2. Reward Responsivity: Probabilistic Reward Task

    Computerized task that requires participants to choose between two stimuli and develop a response bias to the more frequently rewarded stimulus.

    Time frame: Administered at second baseline appointment

  3. Snaith Hamilton Pleasure Scale (SHAPS and SHAPS-C)

    Self-report of anhedonia symptoms

    Time frame: Administered at first baseline appointment and covers past 2 weeks prior to interview

07

Study locations

1 site
  • Queen's University
    Kingston, Ontario K7L 3N6, Canada
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02798094
Lead sponsor
Dr. Kate Harkness
Collaborators
University Health Network, Toronto, University of Calgary, Harvard University, McGill University
Responsible party
Dr. Kate Harkness (Dr., Queen's University) — Sponsor-investigator
First posted
Jun 14, 2016
Start date
Jul 2015
Primary completion
Dec 31, 2018
Completion
Dec 31, 2018
Last update
Aug 28, 2019

Study contacts

Kate Harkness, PhD
principal investigator · Queens University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion